Commission launches new information source on research systems and policies in the EU

ERAWATCHThe Commission is launching ERAWATCH, a new online information platform on research systems and policies within the European Union. ERAWATCH supports the ongoing construction of the European Research Area (ERA) by providing policy makers and policy analysts working in the field of science and research with condensed and updated information and analysis on the development of research systems and policies in all Member States of the European Union plus selected other countries. It contains information on recent policy documents, research programmes, funding agencies, research performance as well as major indicators such as expenditure, publications and patents.

Janez Potočnik, Commissioner for Science and Research said: "Figures released today show that research investment in the EU in 2005 has stagnated. This just goes to show the importance of implementing the measures proposed by the Commission in the Growth and Jobs Strategy in 2005. If we are to see improvement in the future, we need to press on. A fully functioning European Research Area will allow us to make the most of the resources we have and encourage further investment. ERAWATCH is an invaluable service that will allow us to take action to improve the functioning of the European Research Area on the basis of solid and accurate information. I hope to present to the College later this year proposals to revitalise the European Research Area as a major project for Europe's future."

ERAWATCH offers for the first time, in one single place, comprehensive and timely information on the research systems of all EU Member States, countries associated with the Framework Programme as well as the US, China and Japan. It should allow a better understanding of the research systems and the environment in which they operate, to assist European policy analysts and policy makers in developing more effective research policies.

The service is kept up-to-date by a network of national contact organisations who collect and organise the information presented. Within its "Intelligence service", ERAWATCH develops further analyses and reporting activities on research and related policies, as well as on the trends and factors influencing them.

ERAWATCH is a user driven service. Its users can access and customise the way information is presented and downloaded. They are also invited to provide feedback so the service can be developed and improved.

For further information please visit:
http://cordis.europa.eu/erawatch/

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...